Kiniksa Pharmaceuticals International (KNSA) Depreciation and Depletion: 2021-2025
Historic Depreciation and Depletion for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $27,000.
- Kiniksa Pharmaceuticals International's Depreciation and Depletion fell 68.97% to $27,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $163,000, marking a year-over-year decrease of 72.65%. This contributed to the annual value of $448,000 for FY2024, which is 59.60% down from last year.
- According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Depreciation and Depletion is $27,000, which was up 107.69% from $13,000 recorded in Q2 2025.
- In the past 5 years, Kiniksa Pharmaceuticals International's Depreciation and Depletion registered a high of $416,000 during Q2 2021, and its lowest value of $13,000 during Q2 2025.
- Over the past 3 years, Kiniksa Pharmaceuticals International's median Depreciation and Depletion value was $119,000 (recorded in 2024), while the average stood at $148,364.
- In the last 5 years, Kiniksa Pharmaceuticals International's Depreciation and Depletion skyrocketed by 64.97% in 2023 and then slumped by 89.08% in 2025.
- Kiniksa Pharmaceuticals International's Depreciation and Depletion (Quarterly) stood at $376,000 in 2021, then dropped by 21.81% to $294,000 in 2022, then decreased by 19.73% to $236,000 in 2023, then plummeted by 62.71% to $88,000 in 2024, then plummeted by 68.97% to $27,000 in 2025.
- Its Depreciation and Depletion stands at $27,000 for Q3 2025, versus $13,000 for Q2 2025 and $35,000 for Q1 2025.